The Medicines Co. (MDCO)

34.72
NASDAQ : Health Technology
Prev Close 33.76
Day Low/High 32.66 / 35.13
52 Wk Low/High 16.69 / 41.57
Avg Volume 1.22M
Exchange NASDAQ
Shares Outstanding 73.89M
Market Cap 2.50B
EPS -4.00
P/E Ratio N/A
Div & Yield N.A. (N.A)
Medicines Company (MDCO) Reaches New Lifetime High Today

Medicines Company (MDCO) Reaches New Lifetime High Today

Trade-Ideas LLC identified Medicines Company (MDCO) as a new lifetime high candidate

Analysis From CHAMPION PHOENIX Trial Highlight The Efficacy Of Cangrelor Among Patients Undergoing PCI Via The Radial Approach

Analysis From CHAMPION PHOENIX Trial Highlight The Efficacy Of Cangrelor Among Patients Undergoing PCI Via The Radial Approach

Researchers at ESC Congress 2015 presented data from secondary analyses of the CHAMPION PHOENIX trial comparing cangrelor, The Medicines Company's fast-acting, rapid offset, intravenous antiplatelet agent, to oral...

Market News: The Medicine Company, Netflix, Twitter

Market News: The Medicine Company, Netflix, Twitter

The stock markets in the United States declined today with the S&P 500 heading towards its worst month in more than three years. The index dropped 0.84% to 1,972.07 points today. The S&P 500 d...

Market Wrap: Manic Month Ends With a Loss

Energy stocks rally as price of oil climbs.

3 High-Volume Stocks to Trade Now (or Not)

3 High-Volume Stocks to Trade Now (or Not)

Here's a technical look at some of the most active stocks on the market today.

3 Health Care Stocks Nudging The Sector Higher

3 Health Care Stocks Nudging The Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.

Medicines (MDCO) Stock Skyrockets Following Promising Cholesterol Drug Results

Medicines (MDCO) Stock Skyrockets Following Promising Cholesterol Drug Results

Medicines (MDCO) stock is soaring on Monday after the drug maker along with Alnylam Pharmaceuticals (ALNY) announced positive results of a new cholesterol drug.

Medicines Company (MDCO) Moving On Heavy Volume In The Pre-Market Hours

Medicines Company (MDCO) Moving On Heavy Volume In The Pre-Market Hours

Trade-Ideas LLC identified Medicines Company (MDCO) as a pre-market mover with heavy volume candidate

The Medicines Company Appoints Dr. Fred Eshelman As Non-Executive Chairman Of The Board

The Medicines Company Appoints Dr. Fred Eshelman As Non-Executive Chairman Of The Board

The Medicines Company (NASDAQ:MDCO) today announced that its Board of Directors has named Dr.

(Graphic: Business Wire)

(Graphic: Business Wire)

Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, and The Medicines Company (Nasdaq:MDCO), a global biopharmaceutical company focusing on saving lives, alleviating suffering and...

Analysts' Actions -- Akamai, Borg Warner, Urban Outfitters, United States Steel and More

Analysts' Actions -- Akamai, Borg Warner, Urban Outfitters, United States Steel and More

Here are Friday's top research calls, including downgrades for Borg Warner and United States Steel and an upgrade for Akamai Technologies.

The Medicines Company Announces Participation At 2015 European Society Of Cardiology (ESC) Congress In London

The Medicines Company Announces Participation At 2015 European Society Of Cardiology (ESC) Congress In London

The Medicines Company today announced it will present results of recent clinical studies from its cardiovascular product portfolio at the 2015 European Society of Cardiology (ESC) Congress in London, August 29 to September...

The Medicines Co. (MDCO) Stock Price Target Raised at Leerink

The Medicines Co. (MDCO) Stock Price Target Raised at Leerink

The Medicines Co. (MDCO) price target was increased to $40 from $35 at Leerink, which reiterated its 'outperform' rating.

Today's Weak On High Volume Stock: Medicines Company (MDCO)

Today's Weak On High Volume Stock: Medicines Company (MDCO)

Trade-Ideas LLC identified Medicines Company (MDCO) as a weak on high relative volume candidate

The Medicines Company Reports Second-Quarter And First-Half 2015 Financial Results

The Medicines Company Reports Second-Quarter And First-Half 2015 Financial Results

The Medicines Company (NASDAQ:MDCO) today announced its financial results for the second quarter and first half of 2015.

The Medicines Company To Announce Second Quarter Financial Results On Wednesday July 29, 2015

The Medicines Company To Announce Second Quarter Financial Results On Wednesday July 29, 2015

The Medicines Company (NASDAQ:MDCO) has scheduled its quarterly conference call for Wednesday, July 29 th at 8:30 a.

The Medicines Company Authorizes Generic Launch Of ANGIOMAX® (bivalirudin)

The Medicines Company Authorizes Generic Launch Of ANGIOMAX® (bivalirudin)

The Medicines Company (NASDAQ:MDCO) today announced an agreement with Sandoz Inc.

4 Stocks Rising on Unusual Volume

4 Stocks Rising on Unusual Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Strong On High Relative Volume: Medicines Company (MDCO)

Strong On High Relative Volume: Medicines Company (MDCO)

Trade-Ideas LLC identified Medicines Company (MDCO) as a strong on high relative volume candidate

Will Medicines & Co. (MDCO) Stock be Hurt by Court Patent Ruling?

Will Medicines & Co. (MDCO) Stock be Hurt by Court Patent Ruling?

Medicines & Co. (MDCO) shares have been gaining all day before a court ruling on its patent infringement claims against Hospira (HSP).

Federal Circuit Rules Against The Medicines Company In Angiomax® (bivalirudin) Patent Litigation

Federal Circuit Rules Against The Medicines Company In Angiomax® (bivalirudin) Patent Litigation

The Medicines Company (NASDAQ:MDCO) announced the U.S.

Medicines Company (MDCO) Marked As A Barbarian At The Gate

Medicines Company (MDCO) Marked As A Barbarian At The Gate

Trade-Ideas LLC identified Medicines Company (MDCO) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

KENGREAL(TM)(cangrelor)(Photo: Business Wire)

KENGREAL(TM)(cangrelor)(Photo: Business Wire)

The Medicines Company (NASDAQ:MDCO) today announced the approval of KENGREAL™ (cangrelor) by the U.

Insider Trading Alert - CLCT, MDCO And LQ Traded By Insiders

Insider Trading Alert - CLCT, MDCO And LQ Traded By Insiders

Stocks with insider trader activity include CLCT, MDCO and LQ

The Medicines Company To Hold Conference Call On Tuesday, June 2 To Discuss Clinical Trial Results Of ABP-700 And MDCO-216

The Medicines Company To Hold Conference Call On Tuesday, June 2 To Discuss Clinical Trial Results Of ABP-700 And MDCO-216

The Medicines Company (NASDAQ: MDCO) has scheduled a conference call on June 2 at 8:30am EST to discuss results of first phase clinical studies for the investigational anesthetic agent, ABP-700, and the investigational...

Bios/Backgrounders

Bios/Backgrounders

The Medicines Company (NASDAQ:MDCO) announced Phase 1 results for ABP-700, a novel, positive allosteric modulator of the GABA A receptor currently being developed for general anesthesia and procedural sedation.

The Medicines Company Presents New Data Showing Remodeling Effect Of MDCO-216 On HDL Particles In Coronary Artery Disease Patients

The Medicines Company Presents New Data Showing Remodeling Effect Of MDCO-216 On HDL Particles In Coronary Artery Disease Patients

The Medicines Company (NASDAQ:MDCO) presented the results of a Phase 1 study for MDCO-216 that showed that the drug had a significant remodeling effect on HDL particles, which correlated with increased ABCA1-mediated...

The Medicines Company To Participate In The Jefferies 2015 Healthcare Conference

The Medicines Company To Participate In The Jefferies 2015 Healthcare Conference

The Medicines Company (NASDAQ:MDCO) is scheduled to present at the Jefferies 2015 Healthcare Conference in New York, NY on Monday, June 1, 2015 at 10:00 AM EDT.

First Week of January 2016 Options Trading For Medicines (MDCO)

First Week of January 2016 Options Trading For Medicines (MDCO)

Investors in Medicines Co saw new options become available this week, for the January 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

The Medicines Company To Participate In Bank Of America Merrill Lynch 2015 Health Care Conference

The Medicines Company To Participate In Bank Of America Merrill Lynch 2015 Health Care Conference

The Medicines Company (NASDAQ:MDCO) is scheduled to present at the Bank of America Merrill Lynch 2015 Health Care Conference in Las Vegas, NV on Thursday, May 14, 2015 at 10:00 AM PT.

TheStreet Quant Rating: D (Sell)